Childhood-Onset Systemic Lupus Erythematosus (cSLE): An International Perspective

Amita Aggarwal1, Taciana A P Fernandes2, Angela Migowa3

  • 1Department of Clinical Immunology & Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

PubMed

Insights

Childhood-onset systemic lupus erythematosus (cSLE) disproportionately affects children globally. This review highlights disparities in care and research access, emphasizing the urgent need for equitable, worldwide rheumatology services.

Area of Science:

  • Pediatric Rheumatology
  • Autoimmune Diseases
  • Global Health Equity

Background:

  • Childhood-onset systemic lupus erythematosus (cSLE) is a severe autoimmune condition with poorer outcomes than adult-onset lupus.
  • cSLE's global burden is underestimated, with limited data from low-resource settings indicating high morbidity and mortality.
  • Existing research predominantly originates from high-income countries, creating significant knowledge gaps.

Purpose of the Study:

  • To review global disparities in rheumatology care and research access for cSLE patients.
  • To highlight recent cSLE advancements across diverse geographical regions.
  • To identify obstacles hindering cSLE clinical care and research globally and propose solutions.

Main Methods:

  • Comprehensive literature review of cSLE research and clinical practice globally.
  • Analysis of regional data on cSLE prevalence, treatment access, and research output.
  • Synthesis of challenges and proposed strategies for improving global cSLE care.

Main Results:

  • Significant global disparities exist in access to specialized rheumatology care for cSLE.
  • Patients in lower-resourced regions face greater challenges, leading to higher morbidity and mortality rates.
  • Recent cSLE research highlights progress but underscores the need for broader, inclusive studies.

Conclusions:

  • Equitable and accessible care for cSLE is a critical unmet need worldwide.
  • Collaborative, sustained international efforts are essential to improve cSLE patient outcomes.
  • Addressing systemic barriers is crucial for advancing cSLE research and clinical management globally.
Abstract

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
1.8K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
398
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
427